Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

COVID-19 Public Therapeutic Locator: An Important New Resource for Those with CLL/SLL

In science and medicine, information is constantly changing and may become out-of-date as new data emerge. All articles and interviews are informational only, should never be considered medical advice, and should never be acted on without review with your health care team.

We all know that there are significant shortages of the potentially lifesaving medications for treatment and prevention of COVID-19 infections in the immunocompromised, including those with chronic lymphocytic leukemia/ small lymphocytic lymphoma (CLL/SLL).

For some background of this fast-changing situation, please read my recent UPDATE.

Here is how the CDC is alerting healthcare providers about what the newly authorized and already approved medications can and cannot do, and the prioritization plans with such shortages.

There is now a searchable resource including where these very limited medications for COVID-19 treatment and prevention might be found: COVID-19 Public Therapeutic Locator.

We don’t guarantee its accuracy, and remember that in most states (except for maybe in Florida) you will still need a doctor’s order.

Having more information is always good.

CLL Society is working hard with others to push for quicker, wider, and equitable distribution of these preventives and treatments.

Stay strong. We are all in this together.

Brian Koffman, MDCM (retired) MS Ed (he, him, his)
Co-Founder, Executive VP, and Chief Medical Officer
CLL Society, Inc.

RECENT NEWS

When appropriate, the CLL Society will be posting updates and background information on the present Coronavirus pandemic focusing on reliable primary sources of information and avoiding most of the news that is not directly from reliable medical experts or government and world health agencies.